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we explored the influence of the price of apixaban. Conclusions are clearly, 
highly dependent on the assumed price of apixaban for this indication. 
CONCLUSIONS: The results indicate that there is great uncertainty regarding 
which treatment is the cost-effective alternative. Given current evidence, it may 
be too early to conclude that the new oral anticoagulants are cost-effective 
compared to warfarin.  
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OBJECTIVES: To estimate the cost-effectiveness of home telemonitoring (TM) or 
structured telephone support (STS) strategies versus usual care for adults recently 
discharged (within 28 days) after a heart failure (HF) exacerbation in England and 
Wales. METHODS: A Markov model was used to evaluate three interventions: 1) 
STS via human to machine (HM) interface; 2) STS via human to human (HH) 
contact; and 3) TM, against 4) usual care. Given heterogeneity in the interventions, 
cost-effectiveness analysis was performed using bottom up costing scenarios. Costs 
and quality adjusted life years (QALYs) over a 30-year horizon were estimated based 
on monthly probabilities of death and monthly risks of hospitalisations (HF-related 
complications or other causes) estimated from clinical effectiveness parameters 
computed using a network meta-analysis of randomised controlled trials. RESULTS: 
Base case monthly costs per patient were: £27 for usual care, £119 for STS HM, £179 
for STS HH and £175 for TM. TM was the most cost-effective strategy in the scenario 
using these base case costs. Compared with usual care, TM had an estimated 
incremental cost effectiveness ratio (ICER) of £9,552/QALY, whereas STS HH had an 
ICER of £63,240/QALY against TM. STS HM was dominated by usual care. 
Probabilistic sensitivity analysis (PSA) showed 44% chance of TM being cost-
effective with STS HH 36%, STS HM 18% and usual care 2%, respectively. Threshold 
analysis suggested that the monthly cost of TM has to be higher than £390 to have 
an ICER greater than £20,000/QALY against STS HH. Scenario analyses performed 
using higher costs of usual care, higher costs of STS HH and lower costs of TM do 
not substantially change the conclusions. CONCLUSIONS: Cost-effectiveness 
analyses suggest TM was an optimal strategy in most scenarios, but there is 
considerable uncertainty in relation to clear descriptions of the interventions and 
robust estimation of costs.  
 
CARDIOVASCULAR DISORDERS – Patient-Reported Outcomes & Patient 
Preference Studies 
 
PCV102  
ANALYSIS OF THE IMPACT OF PRESCRIPTION SYNCHRONIZATION ON 
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OBJECTIVES: A prescription synchronization and medication management 
program has been implemented in several community pharmacies to enhance 
medication adherence and provide greater efficiency in the pharmacy. The 
objectives of this analysis were to examine the impact of the program on chronic 
medication adherence and health care costs. METHODS: A cross-sectional 
analysis using Mississippi Medicaid claims from 2008-2011 was undertaken. 
Claims for three drug-classes including statins, antihypertensives, and oral 
hypoglycemics were extracted from a pharmacy that implemented the program 
and the other pharmacies serving patients in the same geographic area. First, a 
retrospective matched cohort analysis was undertaken to compare medication 
adherence measured as the proportion of days covered (PDC) and medical costs 
3, 6, 9, and 12 months from the index date. Patients in the two groups were 
matched on age, gender, and race using a greedy-match algorithm. Second, a 
pre-post analysis comparing medication adherence and costs was conducted 
before and after the enrolling in the target pharmacy program. RESULTS: In the 
matched analysis, the average PDC three months (90.87% vs. 84.27%; p=0.002) 
and six months (87.91% vs. 81.86%; p=0.01) after the index date was significantly 
higher in the target pharmacy group than in the other group. Average medical 
costs 3 months ($2,326.52 vs. $1,802.41; p<0.0001) and 12 months ($7,505.36 vs. 
$7,446.77; p=0.04) after the index date were significantly higher in the other 
pharmacy group than in the target pharmacy group. In the pre-post analysis, the 
average PDC before enrolling in the target pharmacy service was significantly 
lower than after enrollment (70.3% vs. 84.2%; p<0.0001). In addition, average 
medical costs per patient per month significantly reduced from $584 in the pre-
period to $420 in the post-period (p<0.0001). CONCLUSIONS: The new service 
was not only associated with improved medication adherence, but also with 
decreased medical expenditures among chronic patients.  
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OBJECTIVES: To understand current medication compliance status of 
hypertension and its associated factors in urban China. METHODS: A 
community-based hypertension health survey was conducted in 2 cities of China 
(Beijing and Hangzhou) from Nov 2011 to Aug 2012. 10 community health service 
centers in each city were selected through cluster sampling. Hypertension 
patients who registered in the study sites were recruited by field investigators 
using standardized questionnaires. Patient data were collected including socio-
demographic characteristics, disease profile, treatment pattern, and health 
education awareness. Medication compliance was assessed by Morisky score. 
Self-reported health utility and social support scale instruments were also 
employed. Logistic regression and multivariate analysis were used to explore the 
associated factors affecting medication compliance in hypertension. RESULTS: In 
total, 1006 patients with hypertension were included, with average age of 
65.26±11.27 years old. 40.85% were male. The average duration of hypertension is 
12.35±10.27 years. 761 patients (75.65%) managed to control blood pressure under 
140/90 mmHG based on last blood pressure detected. 89.76% of the study 
subjects had less than 3 complications. Results show that 67.1% subjects 
achieved high level of compliance, 25.94% were moderate compliant, and 6.96% 
were non-compliant. The main influential factors of non-compliance were 
forgetting to take medicine (57.1%) and self-awareness of disease remission 
(32.6%). Multivariate analysis showed that compliance was positively associated 
with age, disease duration and social support, while negatively associated with 
existence of hypertension complications. Household income and reimbursement 
status were not major factors affecting medication compliance. Patients with 
high level of compliance also reported to have better health utility scores. 
CONCLUSIONS: The compliance status in hypertension in urban China is 
relatively poor. Strengthening family support and implementing effective health 
are important to improve medication compliance in hypertension, which may 
lead to improved patient reported outcomes.  
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OBJECTIVES: Primary non-adherence occurs when a patient does not fill the 
prescription for a newly initiated medication. Contrary to the commonly 
researched concept of medication non-adherence (ie, secondary non-adherence), 
failure to start a new medication is less studied and can potentially pose a 
similar challenge to disease management. Our objective was to observe the 
primary non-adherence rate of newly initiated statins within 6 and 21 days of an 
electronic prescription. This study also explored differences in characteristics 
between primary adherent and non-adherent groups. METHODS: This was a 
retrospective observational study, using electronic prescriptions and pharmacy 
claims and sales records from Scott & White Health Plan (Temple, Texas, USA). 
Adult patients (n=2879) were included in the study if they had no prior exposure 
to any anti-hyperlipidemic drugs and received their first statin prescription from 
September 2009-May 2012. Outcomes measured included primary non-
adherence rates within 6 and 21 days after a new statin prescription was written. 
Characteristics (eg, age, gender, race, Charlson Comorbidity Index, prescriber 
type) were compared between adherent and non-adherent groups using 
descriptive statistics and logistic regression. RESULTS: The 6- and 21-day 
primary non-adherence rates were 29.2% and 21.7%, respectively. Logistic 
regression of 6-day primary adherence revealed that women were less likely to 
be non-adherent than men (OR: 0.815; 95% CI: 0.693–0.960), and African 
Americans were more likely than whites to be non-adherent (OR: 1.486; 95% CI: 
1.107–1.995). Patients were less likely to fill prescriptions written by allied health 
professionals than primary care providers (OR: 0.673; 95% CI: 0.465–0.974). 
CONCLUSIONS: This is one of the few studies to investigate primary non-
adherence in a real-world setting, and the results may be helpful in solving 
another piece of the overall non-adherence puzzle. Exploratory analysis 
indicated that male gender and African American race were predictors of 
primary non-adherence to statins.  
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OBJECTIVES: Despite the rising prevalence of hypertension and the availability 
of evidence-based guidelines for effective treatments, blood pressure (BP) control 
rates remain low. The purpose of this study was to evaluate the effect of 
telephone counseling intervention on blood pressure control. METHODS: Adults 
with hypertension attending the Centre for Diagnosis and Therapy of Arterial 
Hypertension of Cardarelli Hospital, Naples, Italy were randomly allocated to 
receive a pharmacist/counselor-administered counseling intervention (group I) 
or usual care (group C). Group I patients received the counseling intervention bi-
monthly for two years via telephone; the goal of the intervention was to promote 
medication adherence and improve hypertension-related health behaviors. The 
telephone intervention focused on perceived risk of hypertension and 
knowledge, memory, medical and social support, patients' relationship with 
their health care provider, adverse effects of medication therapy, weight 
management, exercise, diet, smoking, and alcohol use. BP values were registered 
at baseline, after one year and at the end of the investigation for both groups. 
Medication adherence (Belief Medicine Questionnaire, BMQ) was also assessed. 
Analysis was performed using SPSS version 19.0 RESULTS: Group I consisted of 
84 patients. A comparable sample was assigned to group C (n=80). The average 
phone call lasted 18 minutes (range 7 to 45 minutes). After two years there was a 
significant reduction of BP values for group I (t=0: Systolic=146.8±2.3 
Diastolic=90.2±4.2, t=24 months Systolic=138.4±4.6 Diastolic=86.9±3.8) (P<0.001). 
From baseline to two years, BMQ analysis showed an adherence improvement in 
group I (t=0 Necessity Score=15.6±3.5, concern Score=14.9±2.9, t=24 Necessity 
Score=22.4±2.4 and Concern Score=10±2.2). Group C did not show any 
statistically significant results. CONCLUSIONS: These findings suggest that 
